Premium
Research Note: The High Photoactivity of m ‐THPC in Photodynamic Therapy. Unusually Strong Retention of m ‐THPC by RIF‐1 Cells in Culture
Author(s) -
Ball Denise J.,
Ver David I.,
Brown Stanley B.
Publication year - 1999
Publication title -
photochemistry and photobiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.818
H-Index - 131
eISSN - 1751-1097
pISSN - 0031-8655
DOI - 10.1111/j.1751-1097.1999.tb03299.x
Subject(s) - photodynamic therapy , chemistry , organic chemistry
— 5,10,15,20‐Tetra( m ‐hydroxyphenyl)chlorin ( m ‐THPC, Foscan) is an extremely powerful photosensitizer showing up to 200 times the photodynamic activity of Photofrin in patients, in terms of drug/light dose. The influence of treatment conditions on the photodynamic efficacy of m ‐THPC has been compared to polyhematoporphyrin (PHP), a Photofrin equivalent, and a cationic pyridinium zinc (II) phthalocyanine (PPC), using the RIF‐1 cell line. As predicted, the presence of serum during sensitizer incubation reduced the photodynamic efficacy of all three sensitizers. However, the presence of serum during the illumination period only had an inhibitory effect with PHP and PPC but not m ‐THPC. Quantification of the intracellular levels of sensitizer revealed that this was due to the efflux of PPC and PHP but not m ‐THPC into the medium, suggesting that m ‐THPC is tightly sequestered on entering the cell. This may partially explain the high efficacy of m ‐THPC in clinical photodynamic therapy and also highlights the importance not only of incubation conditions but also illumination conditions when in vitro comparisons are performed.